Dear OASIS Technical Committee
As the Chairman of the TMF Reference Model Steering Committee and the co-Chair of the TMF Reference Model, I am writing to express my overall concern regarding the lack of alignment between the TMF Reference Model and the OASIS eTMF Standard.
The TMF Reference model was born out of a DIA special interest group in 2009, and has released versions 1.0, 1.1, 1.2 and 2.0 since then.
Number of individuals who have ever been on the TMF Reference Model = 454.
Number of currently members who are part of the ongoing communications= 364
Total number of companies represented since inception = 203
Companies represented listed below:
Aastrom | BD | Clinipace | Eli Lilly | Genzyme | ISI | Mcdougall Scientific | Paragon | QC2 | Shire | United Therapeutics |
Abbott | Biogen Idec | Cognizant | EMA | Gilead | J & J | Medidata | Parexel | Quanticate | Sidley austin | URL Pharma |
Abbvie | Bioventus | Consultant | EMC | | Janssen | Medimmune | Peter MacCallum Cancer Centre | Quintiles | Site - Australia | Veeva |
Actelion | Bluebird | Cordis | EMD Serono | Glemser | | Medi-San | Pfizer | Rammell Consulting | Smith & Nephew (devices) | Vernalis |
Adamas Consulting | Boehringer Ingelheim | Corementum | Endocyte | Global Clincial Conenctions | Kanglaite | MedNet Solutions | Pfizer | Regeneron | Solvay | Vertex |
Advance research associates | | Covance | ePharma Solutions | Grunenthal | Kendle | Medtronics | Pharma Compliance | Registrat-MAPI | Spectrum | Wingspan |
Akros Pharma | Cadence Pharmaceuticals | CRIX International - Quintiles | Epson & St Helliers NHS Trust | GSK | Kids Research Inst, NSW | Merck | Pharmacovigilant | Riverdale Ass | St Vincents, Melbourne | WIPRO |
Alexion | Cambridge Cognition | CSC | eRegulatory Submission | GXPi | Kings College | MHRA | Pharmanet | Roche | Stem Cell Therapeutics | WWCT |
Alkermes | CareLex | Cubist Pharmaceuticals | | Harrison Clinical Research | Kingston Consulting | Millenium | Pharmavigilant | Royal Marsden | Sterling Bio | Xoma |
Allergan | CE3 | Cytrx | Ethicon / J&J | Helicon Therapeutics | Leo Pharma | Mission 3 | Phlexglobal | RQ2 | Sunovian | Xybion |
Alnara | Celerion | Daiichi-Sankyo | FDA | Highpoint Solutions | Life Sciences Integration Partners | Mitsubishi | Photocure | Sacura | Syntax | Zymogenetics |
Amgen | Celgene | Dainippon Sumitoma | Ferring | Human Genome Sciences | Eli Lilly | MMRX | Pierre Fabre | Safe Biopharma | Syntel | |
Antisoma | Centocor | Datatrak | FHI 360 | i3 Research | Lorenz | Montrium | Point Consultancy | Sandoz | Takeda | |
Aris Global | Cephalon | Debra Fadil Consulting | | ICON | Lundbeck | Novo-Nordisk | Pozen | Sanofi Aventis | Target Health | |
Astellas | Cereve | DIA | Fibrogen | IDDI | Lung Rx | NaviGATE | PPD | Sanofi Pasteur | | |
Astra Zeneca | Chiesi | Duke Clinical Research Institute | Forest | Imclone | Malinkrodt | Nektar | PRA | Santen | Teva | |
Auxilium | Chiesi | DW Associates | Galderma | INC Research | MSD | Nextdocs | Premier Research | SBC Global | Tournier | |
Bausch & Lomb | Chiltern | eClinical | GE Healthcare | Integrated Submission Strategies | Mapi | Novartis | Prostrakan (IIT) | Sepian | Transperfect | |
Baxter | Circassia | Edetek | Genentech | Intercept | Mass General Hospital | Otsuka | Purdue | Servier | UCB | |
Bayer | Clinilabs | Eisai | Genprobe | Intralinks | Mcdougall Scientific | Orion Pharma | QA Consultant | SGS | Uni of NSW | |
| | | | | | | | | | |
| | | | | | | | | | | | | | |
Based on the above, our level of expertise has to make us the TMF content experts.
Please can the content then be aligned to our expert input.
Kind regards
Karen
| Karen Roy, Chief Business Development Officer, Phlexglobal Ltd M: +44 (0)7775 708754 DD: +44 (0)1494 720282 T: +44 (0)1494 720420 | E: kroy@phlexglobal.com | |
|
Phlexglobal are worldwide leaders and specialists in the provision of local & global, technology enabled TMF document management solutions and support services.
The information in this E-mail and any attachments to it are confidential in every way and for the sole view of the addressee. If you have received it in error, please accept our apologies and delete it from your system. Thank you. | Any opinions expressed in this message or its attachments are those of the author and are not necessarily those of Phlexglobal Ltd, who disclaim all responsibility and accept no liability for the consequences of anyone acting on the information contained.
Phlexglobal Ltd is a limited company registered in England and Wales under company number 3544670 | VAT No. 108 216 051 | Registered address at Mandeville House, 62 The Broadway, Amersham, Bucks HP7 0HJ, UK